1998
DOI: 10.1046/j.1365-2133.1998.02198.x
|View full text |Cite
|
Sign up to set email alerts
|

Giant oral aphthous ulcers induced by nicorandil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
0
2

Year Published

2004
2004
2016
2016

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(24 citation statements)
references
References 0 publications
0
22
0
2
Order By: Relevance
“…There are also case reports of aphthous-like ulceration arising following the use of beta-blockers such as labetalol (Pradalier et al, 1982), alendronate (Gonzalez-Moles and Bagan-Sebastian, 2000), captopril (Seedat, 1979;Nicholls et al, 1981;Corone et al, 1987;Montoner et al, 1990), nicorandil (Boulinguez et al, 1997;Reichart, 1997;AgboGodeau et al, 1998;Cribier et al, 1998;Desruelles et al, 1998;Roussel et al, 1998;Marquart-Elbaz et al, 1999;Shotts et al, 1999), some non-steroidal anti-inflammatory drugs (NSAIDs) (Siegel and Balciunas, 1991;Healy and Thornhill, 1995), mycophenolate or sirolimus (van Gelder et al, 2003), protease inhibitors (Scully and Diz, 2001), tacrolimus (Hernandez et al, 2001), and sulfonamides, though the exact pathogenic mechanisms are unclear in all of these.…”
Section: (B) Drug-related Aphthous-like Ulcerationmentioning
confidence: 99%
“…There are also case reports of aphthous-like ulceration arising following the use of beta-blockers such as labetalol (Pradalier et al, 1982), alendronate (Gonzalez-Moles and Bagan-Sebastian, 2000), captopril (Seedat, 1979;Nicholls et al, 1981;Corone et al, 1987;Montoner et al, 1990), nicorandil (Boulinguez et al, 1997;Reichart, 1997;AgboGodeau et al, 1998;Cribier et al, 1998;Desruelles et al, 1998;Roussel et al, 1998;Marquart-Elbaz et al, 1999;Shotts et al, 1999), some non-steroidal anti-inflammatory drugs (NSAIDs) (Siegel and Balciunas, 1991;Healy and Thornhill, 1995), mycophenolate or sirolimus (van Gelder et al, 2003), protease inhibitors (Scully and Diz, 2001), tacrolimus (Hernandez et al, 2001), and sulfonamides, though the exact pathogenic mechanisms are unclear in all of these.…”
Section: (B) Drug-related Aphthous-like Ulcerationmentioning
confidence: 99%
“…Il a été commercialisé en France à partir de 1994. Les premiers cas d'ulcé-rations buccales uniques ou multiples, mimant des aphtes géants, imputées à ce médicament ont été publiés dans la littérature dès 1997, surtout par des auteurs français [6][7][8][9][10]. Dans une étude prospective, Marquart-Elbaz et al ont retrouvé une prévalence des ulcérations buccales d'environ 5 % chez les patients traités par nicorandil [11].…”
Section: Discussionunclassified
“…La langue est le plus souvent atteinte par une ulcération unique mais d'autres muqueuses buccales (labiale, jugale, palatine et gingivale) peuvent être concernées par des lésions multiples simultanées ou non avec l'ulcération linguale [6][7][8][9][10][11][12][14][15][16]. Un antécédent d'aphtose récidivante a été retrouvé chez une partie des patients [7,8,11].…”
Section: Discussionunclassified
“…There has been suggestion that there is a minimal dose required to induce oral ulceration 4 or that there may be a dose dependent mechanism in place since in some reported cases the ulceration is induced after there is an increase in the Nicorandil dose. 6 In the patients reported here the ulceration occurs across a range of doses from 20-60 mg per day; other reports have shown oral ulceration from 10-80 mg (across the recommended dose range).…”
Section: Discussionmentioning
confidence: 99%